Tacconi et al. [21] reported that VEGF-C binding to VEGFR3 on lymphatic vessels inhibited the expression of vascular endothelial cadherin (VE-Cad), resulting in damage to the endothelial barrier of lymphatic vessels around the tumor. The gene discussed is VEGFC; the disease is neoplasm.